On behalf of the HESI Cell Therapy – TRAcking, Circulation, & Safety (CT-TRACS) Committee, Visicell CEO Mya Thu will be co-speaking with...

VisiCELL Medical Inc. is delighted to receive the National Science Foundation (NSF) SBIR Phase I grant award to further develop and...